A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes

Page view(s)
10
Checked on Mar 24, 2024
A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes
Title:
A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes
Journal Title:
Clinical Nutrition
Publication Date:
28 January 2013
Citation:
Ataie-Jafari A, Loke SC, Rahmat AB, et al. A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes. Clin Nutr. 2013;32(6):911‐917. doi:10.1016/j.clnu.2013.01.012
Abstract:
Background & aims: This participant-blinded parallel-group randomized placebo-controlled study demonstrated that alfacalcidol (vitamin D analogue) preserves beta cell function in newly diagnosed type 1 diabetes (T1DM) in children. Methods: Subjects from outpatient clinic were randomized to intervention and control groups. Inclusion: (1) age 8e15, (2) T1DM, (3) duration
License type:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Funding Info:
The study was run using internal funding from the Endocrinology and Metabolism Research Center (EMRC), Tehran University of Medical Sciences.
Description:
ISSN:
0261-5614
1532-1983
Files uploaded: